← Browse by Condition
Medical Condition

high risk prostate carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06384222 Phase 2
Recruiting

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone

Enrollment
32 pts
Location
United States
Sponsor
Ivan de Kouchkovsky, MD
View Trial →